Position in BIIB
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,188,330
+$180,015 QoQ
Shares Held
5,500
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#426
of 1,031 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GUARDIAN INVESTMENT MANAGEMENT holds $13,312,413 across 7 Drug Manufacturers - General names. BIIB ranks #4 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,205 | $5,868,154 | |
| 2 | ABBV |
AbbVie Inc.
|
12,425 | $3,126,627 | |
| 3 | JNJ |
Johnson & Johnson
|
7,907 | $2,008,140 | |
| 4 | BIIB |
Biogen Inc.
This page
|
5,500 | $1,188,330 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,750 | $473,775 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,300 | $420,626 | |
| 7 | PFE |
Pfizer Inc
|
9,417 | $226,761 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,188,330 | 5,500 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,008,315 | 5,500 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $950,346 | 5,400 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $756,432 | 5,400 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $665,627 | 5,300 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $998,932 | 7,300 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $1,116,316 | 7,300 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,970,383 | 10,165 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $2,356,450 | 10,165 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,191,878 | 10,165 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $2,630,397 | 10,165 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,586,805 | 10,065 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $2,867,015 | 10,065 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $2,992,992 | 10,765 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $2,814,891 | 10,165 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $2,714,055 | 10,165 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $2,073,050 | 10,165 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $2,140,749 | 10,165 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $2,438,786 | 10,165 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $2,876,593 | 10,165 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $3,692,969 | 10,665 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $3,011,508 | 10,765 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $2,660,403 | 10,865 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $2,968,711 | 10,465 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,799,910 | 10,465 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $3,279,278 | 10,365 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||